Modifier Effects in Autism at the MAO-A and DBH Loci

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 126 B, Issue 1, 2004, Pages 58-65

  Jones, Marshall B ^a   Palmour, Roberta M ^b   Zwaigenbaum, Lonnie ^c   Szatmari, Peter ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Autism; Catecholamires; DBH; Genetics; MAO A

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CATECHOLAMINE DERIVATIVE; DOPAMINE BETA MONOOXYGENASE;

ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; DEVELOPMENTAL DISORDER; FEMALE; FETUS; GENE FREQUENCY; GENE LOCUS; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETICS; GENOTYPE; HUMAN; INTELLIGENCE QUOTIENT; MALE; PRIORITY JOURNAL; SIBLING; SOCIAL INTERACTION; STEREOTYPY;

EID: 1842591872     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20172     Document Type: Article

References (55)

1. Abramson RK, Wright HH, Carpenter R, Brennan W, Lumpuy O, Cole E, Young SR. 1989. Elevated blood serotonin in autistic probands and their first-degree relatives. J Autism Dev Disord 19:397-407.
2. American Psychiatric Association. 1980. Diagnostic and statistical manual of mental disorders, 3rd edition. Washington, DC: Author.
3. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC: Author.
4. Anderson GM. 1987. Monoamines in autism: An update of neurochemical research on a pervasive developmental disorder. Med Biol 65:67-74.
5. Anderson GM, Freedman DX, Cohen DJ, Volkmar FR, Hoder EL, McPhedran P, Minderaa RB, Hansen CR, Young JG. 1987. Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 28(6):885-900.
6. Campbell M, Freidman E, DeVito E, Greenspan L, Collins PJ. 1974. Blood serotonin in psychotic and brain damaged children. J Autism Child Schizophr 4:33-41.
7. Cook EH. 1990. Autism: Review of neurochemical investigation. Synapse 6:292-308.
8. Cook EH, Leventhal BL. 1996. The serotonin system in autism. Curr Opin Pediatr 8:348-354.
9. Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, Calafell F, Kranzler HR, Ichinose H, Gelernter J. 1997. Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet 74:374-379.
10. Cubells JF, van Kammen DP, Kelley ME, Anderson GM, O'Connor DT, Price LH, Malison R, Rao PA, Kobayashi K, Nagatsu T, Gelernter J. 1998. Dopamine β-hydroxylase: Two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 102:533-540.
11. Dean JC, Moore SJ, Osborne A, Howe J, Turnpenny PD. 1999. Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene. Clin Genet 56(3):216-220.
12. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nöthen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP. 1999. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624.
13. Folstein SE, Rosen-Sheidley B. 2001. Genetics of autism: Complex aetiology for a heterogeneous disorder. Nat Rev Genet 2(12):943-955.
14. Folstein S, Rutter M. 1991. Family History Interview for Developmental Disorders of Cognition and Social Functioning (available from authors).
15. Gutknecht L. 2001. Full-genome scans with autistic disorder: A review. Behav Genet 31(1):113-123.
16. Hanley HG, Stahl SM, Freedman DX. 1977. Hyperserotonemia and amine metabolites in autistic and retarded children. Arch Gen Psychiatry 34:521-531.
17. Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Hine RJ, Pogribna M, Rozen R, James SJ. 2000. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down Syndrome. Am J Hum Genet 67:623-630.
18. Holschneider DP, Shih JC. 2000. Genotype to phenotype: Challenges and opportunities. Int J Dev Neurosci 18(6):615-618.
19. Houlston RS, Tomlinson IP. 1998. Modifer genes in humans: Strategies for identification. Eur J Hum Genet 6(1):80-88.
20. Ishii A, Kobayashi K, Kiuchi K, Nagatsu T. 1991. Expression of two forms of human dopamine β-hydroxylase in COS cells. Neurosci Lett 125:25-28.
21. James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW. 1999. Abnormal folate metabolism and mutation in the methylenetetrahdrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70(4):495-501.
22. Kuperman S, Beeghly JH, Burns TL, Tsai LY. 1985. Serotonin relationships of autistic probands and their first-degree relatives. J Am Acad Child Psychiatry 24(2):186-190.
23. Kuperman S, Beeghly JH, Burns TL, Tsai L. 1987. Association of serotonin concentration to behavior and IQ in autistic children. J Autism Dev Disord 17:133-140.
24. Leventhal BL, Cook EH Jr, Morford M, Ravitz A, Freedman DX. 1990. Relationships of whole blood serotonin and plasma norepinephrine within families. J Aut Dev Disord 20(4);499-511.
25. Levine MN. 1986. Arthur Adaptation of the Leiter International Performance Scale: A handbook. Montreal: Montreal Institute of Psychological Research.
26. Levy HL, Waisbren SE. 1983. Effects of untreated maternal phenylketonuria and hyperphenylalaninenemia on the fetus. N Engl J Med 309:1269-1274.
27. Li B, Tsing S, Kosaka AH, Nguyen B, Osen EG, Bach C, Chan H, Barnett J. 1996. Expression of human dopamine β-hydroxlase in Drosophila Schneider 2 cells. Biochem J 313:57-64.
28. Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, Scholper E. 1989. Autism diagnostic observation schedule: A standardized observation of communicative and social behavior. J Autism Dev Disord 19(2):185-212.
29. Lord C, Rutter M, Le Couteur A. 1994. Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible Pervasive Developmental Disorders. J Aut Dev Disord 24:659-685.
30. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore P, Pickles A, Rutter M. 2000. The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30(3):205-223.
31. MacLean JE, Szatmari P, Jones MB, Bryson SE, Mahoney WJ, Bartolucci G, Tuff L. 1999. Familial factors influence level of functioning in pervasive developmental disorder. J Am Acad Child Adoles Psychiatry 38(6):746-753.
32. Mahoney WJ, Szatmari P, MacLean JE, Bryson SE, Bartolucci G, Walter SD, Jones MB, Zwaigenbaum L. 1998. Reliability and accuracy of differentiating pervasive developmental disorder subtypes. J Am Acad Child Adolesc Psychiatry 37(3):278-285.
33. Medical Research Council Working Party on Phenylketonuria. 1993. Phenylketonuria due to phenylalanine hydroxylase deficiency: An unfolding story. Education and debate. BMJ 306:115-119.
34. Miller JN, Ozonoff S. 1997. Did Asperger's cases have Asperger disorder? A research note. J Child Psychol Psychiatry 38(2):247-251.
35. Mitchell LE. 1997. Differentiating between fetal and maternal genotypic effects, using the transmission test for linkage disequilibrium. Am J Hum Genet 60(4):1006-1007.
36. Nadeau JH. 2001. Modifer genes in mice and humans. Nat Rev Genet 2(3):165-174.
37. Nadeau JH. 2003. Genetics: Modifying the message. Science 301(5635):927-928.
38. Pickles A, Starr E, Kazak S, Bolton P, Papanikolaou K, Bailey A, Goodman R, Rutter M. 2000. Variable expression of the autism broader phenotype: Findings from extended pedigrees. J Child Psychol Psychiatry 41(4):491-502.
39. Piven J. 2001. The broad autism phenotype: A complementary strategy for molecular genetic studies of autism. Am J Med Genet 105(1):34-35.
40. Sabol SZ, Hu S, Hamer D. 1998. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103:273-279.
41. Schaid DJ, Sommer SS. 1993. Genotype relative risks: Methods for design and analysis of candidate-gene association studies. Am J Hum Genet 53:1114-1126.
42. Sparrow SS, Balla D, Cicchetti D. 1984. Vineland adaptive behavior scales (survey form). Circle Pines, MN: American Guidance Service.
43. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52(3):506-516.
44. Starr E, Szatmari P, Bryson SE, Zwaigenbaum L. 2003. Stability and change among high functioning children with pervasive developmental disorders: A two-year outcome study. J Aut Develop Disord 33(1):15-22.
45. Stevenson RE, Huntley CC. 1967. Congenital malformations in offspring of phenylketonuric mothers. Pediatrics 40(1):33-45.
46. Szatmari P, Archer L, Fisman S, Streiner DL, Wilson FJ. 1995. Asperger's syndrome and autism: Differences in behavior, cognition and adaptive functioning. J Am Acad Child Adolesc Psychiatry 34(12):1662-1671.
47. Szatmari P, Jones MB, Zwaigenbaum L, MacLean JE. 1998. Genetics of autism: Overview and new directions. J Aut Dev Dis 28(5):351-368.
48. Szatmari P, MacLean JE, Jones MB, Bryson SE, Zwaigenbaum L, Bartolucci G, Mahoney WJ, Tuff L. 2000. The familial aggregation of the lesser variant in biological and non-biological relatives of PDD probands: A family history study. J Child Psychol Psychiatry 41(5):579-586.
49. Tanguay PE. 2000. Pervasive developmental disorders: A 10 year review. J Am Acad Child Adolesc Psychiatry 39(9):1079-1095.
50. Thomas SA, Matsumoto AM, Palmiter RD. 1995. Noradrenaline is essential for mouse fetal development. Nature 374(6523):643-646.
51. Waterhouse L, Morris R, Allen D, Dunn M, Fein D, Feinstein C, Rapin I, Wing L. 1996. Diagnosis and classification in autism. J Autism Dev Dis 26(1):59-86.
52. Weinberg CR, Wilcox AJ, Lie RT. 1998. A log-linear approach to case-parent-triad data: Assessing effective disease genes that act either directly or through maternal effect and that may be subject to parental imprinting. Am J Hum Genet 62(4):969-978.
53. Williams RB, Marchuk DA, Gadde KM, Barefoot JC, Grichnik K, Helm MJ, Kuhn CM, Lewis JG, Schanberg SM, Stafford-Smith M, Suarez EC, Clary GL, Svenson IK, Siegler IC. 2003. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharm 28(3):533-541.
54. Yirmiya N, Pilowsky T, Tidhar S, Nemanov L, Altmark L, Ebstein RP. 2002. Family-based and population study of a functional promotor-region monoamine oxidase A polymorphism in autism: Possible association with IQ. Am J Med Genet 114(3):284-287.
55. Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, Nagatsu T, Kim KS, Kim CH, Malison RT, Gelernter J, Cubells JF. 2001. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: Evidence for a major functional polymorphyism at the DBH locus. Am J Hum Genet 68(2):515-522.